Trialwell Secures £ 195k Pre-Seed Investment From Nova – UK Technology Investment News

Liverpool UK Liverpool-based business builder, Novaannounced an investment of £ 195,000 in Test well – an online digital platform that allows quick and easy access to clinical trials completely free of charge.

The launch will allow the general public to easily discover and enroll in a variety of clinical trials. Users can take care of their health and well-being, supporting the further development of new treatments and preventative strategies for all.

Using AI technology, Trialwell matches users’ health profile to upcoming clinical trials and resources best suited to their personal health profile and wellness goals.

Laura Holland, Ph.D., social impact entrepreneur and founder of Trialwell, presented her concept to the Nova investment panel earlier this year. She won them over with her dedication to empowering people and her commitment to making clinical trials and research more accessible.

Speaking to Laura, she commented: “I am thrilled to have secured the investment in Trialwell from Nova Growth Capital and thrilled to grow our journey together. Having worked in the industry for many years, one of the main challenges we face is a significant lack of awareness of clinical trials and their potential as a source of help. Especially the trials that study natural treatments and preventative drugs, which could be useful for many of us.

We need to democratize access to clinical trials and the latest science-based health advice. We aim to improve the health and well-being of millions of people around the world. We are here to support everyone in their path of health and well-being ”.

On Nova’s investment in Trialwell, Olivia Greenberg, Nova’s Chief Growth Officer, who sits on the investment committee at the venture builder, commented: “We are delighted to welcome Laura and the Trialwell team on board. Laura’s passion and commitment to help people’s health and well-being is what led us to invest in this startup. We firmly believe that this venture will have a positive impact on the health and well-being of many. This is something that we at Nova are excited to be a part of ”.

Nova Growth Capital’s investment includes not only capital, but also the experience of the venture building team that will be employed to build and market the platform. The founder of Trialwell now has access to Nova’s product developers, marketing team, videographers, corporate mentors and more.


About Trialwell:

Trialwell is an online platform that offers users access to clinical trials in health, wellness and preventive medicine based on their individual health profile, completely free of charge.

Joining clinical trials and trials offers users the opportunity to access and potentially benefit from innovative treatments and therapies, while contributing to vital research. The results of clinical trials may lead to the development of medicines and interventions that can prevent thousands of deaths each year and also improve the lives of thousands of other people suffering from various health conditions. Trialwell has a strong focus on clinical trials researching drugs and interventions in the areas of traditional, complementary and integrative health care and preventive medicine.


About Nova

Nova is a Liverpool-based venture builder and investment fund, launched in 2009. It works with entrepreneurs to transform ideas into scalable and successful tech startups in industries including health-tech, fintech and edtech.

With no personal capital investment required, Nova offers entrepreneurs mentoring, guidance and funding. He invests in the idea stage and, through his team of over 20 startup mentors, as well as over 100 designers, software engineers and marketers globally, takes startups from idea, to product, to market.

Nova becomes a shareholding business partner in each of the startups it supports. Its startup success rate is six times the industry average.

For more information please contact

Michael Craven, Marketing Manager, Nova

[email protected]

Digiqole announcement

Trialwell Secures £ 195k Pre-Seed Investment From Nova – UK Technology Investment News

Source link Trialwell Secures £ 195k Pre-Seed Investment From Nova – UK Technology Investment News

Back to top button